Old Web
Improving survival rates for patients with acute myeloid leukemia: Impacts of fludarabine/busulfan and antithymocyte globulin as reduced toxicity myeloablative conditioning for matched related donor allo-HCT.
2020
Current Research in Translational Medicine - Sous presse. Epreuves corrigees par l'auteur. Disponible en ligne depuis le lundi 5 octobre 2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI